Home » MiddleBrook Pharmaceuticals Sells Product Line to Bolster Financial Position
MiddleBrook Pharmaceuticals Sells Product Line to Bolster Financial Position
MiddleBrook Pharmaceuticals Inc. is selling its Keflex antibiotic line to a major shareholder for $7.5 million, money the biotech will use to continue negotiating a potential sale or partnership into next year.
Washington Business Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May